Integration of Metabolomics and 16S Ribosomal RNA Sequencing to Elucidate the Pathogenesis of Ankylosing Spondylitis
Immunity, Inflammation and Disease · 2025
DOI: 10.1002/iid3.70183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Xin Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, RNA, Ribosomal, 16S, Gastrointestinal Microbiome, Metabolomics. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research is supported by Natural Science Research Project of Anhui Educational Committee (2022AH051494), Anhui Provincial Key R&D Programmers (20230429510….
Abstract (Originalsprache)
Objective
Despite growing interest in the gut microbiota and blood metabolome in patients with ankylosing spondylitis (AS), its role remains poorly understood. Here, we investigate how microbial and metabolic alterations contribute to AS.
Methods
Fecal microbiome data from 40 AS patients were compared with those from 40 healthy controls (HCs) using 16S ribosomal RNA (rRNA) gene sequencing. The plasma metabolic profiles were analyzed and integrated with the microbiota data to identify biological characteristics specific to AS.
Results
AS patients showed significant enrichment of specific genera, including Megamonas, Elusimicrobium, Dysgonomonas, Ruminococcus_gauvreauii_group , and unclassified_Prevotellaceae . Pathways with the most differentially expressed metabolites included bile secretion; neomycin, kanamycin, and gentamicin biosynthesis; and arachidonic acid metabolism. Positive correlations between Megamonas and Elusimicrobium and metabolites such as piribedil, l ‐cystathionine, and crocetin dialdehyde suggested microbial enrichment in AS patients.
Conclusions
A disrupted gut microbiota and altered metabolites are present in AS patients. Integrating microbiome and metabolomic data reveals significant disruptions in AS patients, improving our understanding of its pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Anhui Province Key Laboratory of Immunology in Chronic Diseases, Bengbu, China.
- Anhui Province Key Laboratory of Basic and Translational Research of Inflammation-Related Diseases, Bengbu, China.
- Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
ORCID-Profile: Haojie Xu, Changhao Xie
Förderung
- This research is supported by Natural Science Research Project of Anhui Educational Committee (2022AH051494), Anhui Provincial Key R&D Programmers (20230429510…
Zitieren
APA
Wang, X., Xu, H., Chao, Y., Sun, C., Wang, T., Fan, X., Tang, L., Xu, S., & Xie, C. (2025). Integration of Metabolomics and 16S Ribosomal RNA Sequencing to Elucidate the Pathogenesis of Ankylosing Spondylitis. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70183
Vancouver
Wang X, Xu H, Chao Y, Sun C, Wang T, Fan X, et al. Integration of Metabolomics and 16S Ribosomal RNA Sequencing to Elucidate the Pathogenesis of Ankylosing Spondylitis. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70183
BibTeX
@article{Wang2025,
author = {Wang, Xin and Xu, Haojie and Chao, Yuyan and Sun, Chao and Wang, Tingting and Fan, Xiaoyun and Tang, Lin and Xu, Shengqian and Xie, Changhao},
title = {Integration of Metabolomics and 16S Ribosomal RNA Sequencing to Elucidate the Pathogenesis of Ankylosing Spondylitis},
journal = {Immunity, Inflammation and Disease},
year = {2025},
doi = {10.1002/iid3.70183}
}
EUVIMED